AR034677A1 - Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado - Google Patents

Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado

Info

Publication number
AR034677A1
AR034677A1 ARP020102478A ARP020102478A AR034677A1 AR 034677 A1 AR034677 A1 AR 034677A1 AR P020102478 A ARP020102478 A AR P020102478A AR P020102478 A ARP020102478 A AR P020102478A AR 034677 A1 AR034677 A1 AR 034677A1
Authority
AR
Argentina
Prior art keywords
mycoplasma
vaccine
methods
bovis
livestock
Prior art date
Application number
ARP020102478A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR034677A1 publication Critical patent/AR034677A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos para tratar o prevenir una enfermedad o trastorno en un animal causado por infección con Mycoplasma bovis (M. bovis) mediante la administración al animal de una cantidad eficaz de una vacuna de Mycoplasma hyopneumoniae (M. hyo). La vacuna de M. hyo puede ser una preparación de células totales o parciales de células vivas inactivadas o modificadas, una vacuna de subunidades o una vacuna de ácidos nucleicos o ADN. La vacuna de M. hyo administrada de acuerdo con la presente se puede sintetizar o producir de forma recombinante.
ARP020102478A 2001-07-02 2002-07-01 Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado AR034677A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30258601P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
AR034677A1 true AR034677A1 (es) 2004-03-03

Family

ID=23168382

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102478A AR034677A1 (es) 2001-07-02 2002-07-01 Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado

Country Status (9)

Country Link
US (1) US7056492B2 (es)
EP (1) EP1521592A2 (es)
JP (1) JP2004537543A (es)
CN (1) CN1612749A (es)
AR (1) AR034677A1 (es)
BR (1) BR0211049A (es)
CA (1) CA2452666A1 (es)
MX (1) MXPA03011924A (es)
WO (1) WO2003004051A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1571633A (zh) * 2001-08-28 2005-01-26 辉瑞产品公司 牛支原体刺激模型及施用牛支原体的方法以及诱导肺炎损伤的方法
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UY31437A1 (es) * 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
MX2010005014A (es) 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
DK2310046T3 (da) * 2008-06-27 2016-04-25 Zoetis Services Llc Hidtil ukendte adjuvanssammensætninger
CN102202685A (zh) * 2008-10-31 2011-09-28 贝林格尔.英格海姆维特梅迪卡有限公司 包含来自牛枝原体的抗原的多种抗原在多价疫苗组合物中的用途
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CA2762587C (en) * 2009-05-19 2017-11-28 Bioproperties Pty Ltd A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
CA2822359C (en) * 2010-12-22 2021-06-01 Bayer Intellectual Property Gmbh Enhanced immune response in bovine species
CA2866199A1 (en) * 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN104981252B (zh) 2012-12-28 2019-06-18 勃林格殷格翰动物保健有限公司 包含支原体抗原的免疫原性组合物
BR112015012711B1 (pt) 2012-12-28 2022-08-16 Boehringer Ingelheim Vetmedica Gmbh Método para preparar uma composição imunogênica para o tratamento e/ou a profilaxia de infecções por mycoplasma
WO2015035474A1 (en) * 2013-09-16 2015-03-19 The University Of Melbourne Serological test
EP3046580A2 (en) 2013-09-19 2016-07-27 Zoetis Services LLC Oil-based adjuvants
US9951109B2 (en) * 2013-11-21 2018-04-24 Agricultural Technology Research Institute Composition for preventing Mycoplasma spp. infection
RU2740492C2 (ru) 2014-02-28 2021-01-14 Байер Энимэл Хельс ГмбХ Иммуностимулирующие плазмиды
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
PT3244920T (pt) 2015-01-16 2023-07-28 Zoetis Services Llc Vacina contra a febre aftosa
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
CN111856005B (zh) * 2020-06-22 2021-07-30 华中农业大学 牛支原体分泌蛋白MbovP280的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7682091A (en) * 1990-04-02 1991-10-30 Synergen, Inc. Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures

Also Published As

Publication number Publication date
BR0211049A (pt) 2004-07-20
EP1521592A2 (en) 2005-04-13
US7056492B2 (en) 2006-06-06
WO2003004051A2 (en) 2003-01-16
US20030064079A1 (en) 2003-04-03
WO2003004051A3 (en) 2005-02-17
JP2004537543A (ja) 2004-12-16
CN1612749A (zh) 2005-05-04
MXPA03011924A (es) 2004-03-26
CA2452666A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
AR034677A1 (es) Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado
UY27365A1 (es) Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales
UY27366A1 (es) Vacunación en dosis única con mycoplasma hyopneumoniae
RU2008105348A (ru) Вакцина на основе lawsonia и способы ее применения
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BRPI0010612B8 (pt) vacinas
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
BR0208896A (pt) Vacina contra o vìrus da febre do nilo
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
US7910620B2 (en) Uses of neuraminidase inhibitors in infectious diseases
JP3701304B2 (ja) 皮膚糸状菌症用ワクチン
MX2023005154A (es) Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19).
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
RU2539105C1 (ru) Препарат для лечения некробактериоза крупного рогатого скота
RU2213573C2 (ru) Способ профилактики паратифа телят
RU2230505C2 (ru) Способ профилактики туберкулеза крупного рогатого скота
RU2240820C2 (ru) Средство для профилактики инфекционного кератоконъюнктивита крупного рогатого скота и способ профилактики этого заболевания
HN2002000163A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
TH64472A (th) การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae
Meyer et al. Further Studies on the Pathogenicity of Br. Abortus and Br. Melitensis for Monkeys
RU2164147C2 (ru) Комплексная вакцина против трихофитии и микроспории пушных зверей, кроликов, собак и кошек
RU94023126A (ru) Вакцина против пастереллеза свиней
Richey Pasteurella Disease in Beef Cattle
UA12940U (en) Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals

Legal Events

Date Code Title Description
FB Suspension of granting procedure